DE60037012D1 - Inhibitoren der endothelin-1 synthese - Google Patents

Inhibitoren der endothelin-1 synthese

Info

Publication number
DE60037012D1
DE60037012D1 DE60037012T DE60037012T DE60037012D1 DE 60037012 D1 DE60037012 D1 DE 60037012D1 DE 60037012 T DE60037012 T DE 60037012T DE 60037012 T DE60037012 T DE 60037012T DE 60037012 D1 DE60037012 D1 DE 60037012D1
Authority
DE
Germany
Prior art keywords
endothelin
synthesis
inhibitors
mrna
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60037012T
Other languages
English (en)
Other versions
DE60037012T2 (de
Inventor
Roger Corder
Adrian P L Smith
Timothy W Higenbottam
Martine Rothblatt
Sir John William Harvey R Vane
Delphine Dominique Lees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Publication of DE60037012D1 publication Critical patent/DE60037012D1/de
Application granted granted Critical
Publication of DE60037012T2 publication Critical patent/DE60037012T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
DE60037012T 1999-03-18 2000-03-17 Inhibitoren der endothelin-1 synthese Expired - Fee Related DE60037012T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12500099P 1999-03-18 1999-03-18
US125000P 1999-03-18
PCT/US2000/040074 WO2000055314A2 (en) 1999-03-18 2000-03-17 Inhibitors of endothelin-1 synthesis

Publications (2)

Publication Number Publication Date
DE60037012D1 true DE60037012D1 (de) 2007-12-20
DE60037012T2 DE60037012T2 (de) 2008-10-30

Family

ID=22417780

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60037012T Expired - Fee Related DE60037012T2 (de) 1999-03-18 2000-03-17 Inhibitoren der endothelin-1 synthese

Country Status (8)

Country Link
US (1) US7423141B2 (de)
EP (1) EP1163333B1 (de)
AT (1) ATE377645T1 (de)
AU (1) AU3934000A (de)
DE (1) DE60037012T2 (de)
ES (1) ES2296613T3 (de)
PT (1) PT1163333E (de)
WO (1) WO2000055314A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526534C (en) 2003-05-22 2011-07-12 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
EP3168618B1 (de) 2006-04-04 2018-11-21 Singulex, Inc. Hochempfindliche verfahren zur troponinanalyse
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
JP2010518122A (ja) * 2007-02-09 2010-05-27 ユナイテッド セラピューティクス コーポレーション 間質性肺疾患および喘息のためのトレプロスチニル処置
JP5678045B2 (ja) 2009-06-08 2015-02-25 シンギュレックス・インコーポレイテッド 高感度バイオマーカーパネル
WO2016083624A1 (en) * 2014-11-28 2016-06-02 Silence Therapeutics Gmbh Means for inhibiting the expression of edn1
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
JP7431837B2 (ja) 2018-10-05 2024-02-15 ゼノセラピューティクス インコーポレイテッド 異種移植製品及び異種移植方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
JP2632167B2 (ja) * 1987-11-30 1997-07-23 鐘淵化学工業株式会社 熱硬化性組成物
EP0347243B1 (de) * 1988-06-17 1993-01-13 The Wellcome Foundation Limited Prostaglandinanaloge zur Verwendung in der Medizin
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5747340A (en) * 1994-06-03 1998-05-05 Syntex (U.S.A.) Inc. Targeted gene expression using preproendothelin-1 promoters
JPH10508830A (ja) * 1994-09-14 1998-09-02 プレジデント アンド フェロウズ オブ ハーバード カレッジ 炎症過程を抑制するためのエンドセリン−１の阻害
US5688499A (en) * 1996-03-13 1997-11-18 Queen's University At Kingston Antagonism of endothelin actions
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
GB9718487D0 (en) * 1997-09-02 1997-11-05 Univ Sheffield Pulmonary hypertension
AU1373499A (en) * 1997-11-14 1999-06-07 United Therapeutics Corporation Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics

Also Published As

Publication number Publication date
EP1163333B1 (de) 2007-11-07
US20030109480A1 (en) 2003-06-12
WO2000055314A9 (en) 2002-08-08
EP1163333A2 (de) 2001-12-19
WO2000055314A3 (en) 2001-02-22
AU3934000A (en) 2000-10-04
PT1163333E (pt) 2008-02-19
WO2000055314A2 (en) 2000-09-21
ES2296613T3 (es) 2008-05-01
US7423141B2 (en) 2008-09-09
ATE377645T1 (de) 2007-11-15
DE60037012T2 (de) 2008-10-30

Similar Documents

Publication Publication Date Title
CY1110936T1 (el) Θεραπεια μελανωματος με μειωση των επιπεδων της clusterin
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ATE451930T1 (de) Verwendung von il-18-hemmern zur behandlung oder prävention von sepsis
TR200401545T4 (tr) NOSS inhibitörü ilaçların amalatı için ikame imidazo [1,2-a]piridin-,-pirimidin- ve-pirazin-3-amin-türevlerinin kullanımı
SG151303A1 (en) New compounds for the inhibition of angiogenesis and use thereof
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
ATE323490T1 (de) Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung
ATE452642T1 (de) Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen
DE60037012D1 (de) Inhibitoren der endothelin-1 synthese
DE60234329D1 (de) Glycerin-peg-derivate als inhibitoren der cyclooxigenase-2 und der phospholipase-a2
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
ATE534380T1 (de) Glepp-1-hemmer bei der behandlung von autoimmun- und/oder entzündungskrankheiten
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
DE60123138D1 (de) Verwendung von progesteronrezeptorhemmern zur behandlung von steroid-resistentem brustkrebs
DE60137721D1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
EE200300582A (et) IL-18 inhibiitorite kasutamine kesknärvisüsteemi kahjustuste raviks või ennetamiseks
DK1042288T3 (da) Tripeptidyl-peptidase inhibitorer
HUP0100105A2 (hu) TNF-antagonisták alkalmazása szeptikus betegségek kezelésére szolgáló gyógyszerként
RS95304A (en) New combination fortreating airway disorders
NO992985L (no) Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
DE10193322D2 (de) Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee